Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 8Peritoneal Neoplasms 4Stomach Neoplasms 1Recurrence 1Postoperative Complications 1Peritoneal Cancer 1Neoplasms 1Neoplasm, Residual 1Lymphatic Metastasis 1Low Anterior Resection Syndrome 1Fallopian Tube Neoplasms 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Blood Specimen Collection 6Liquid Biopsy 3Chemotherapy, Adjuvant 2trastuzumab deruxtecan 1pegaspargase 1Vincristine 1Trastuzumab 1Transplantation, Autologous 1Prednisone 1Neoadjuvant Therapy 1Methotrexate 1Mercaptopurine 1Hematologic Tests 1Drug Therapy 1Doxorubicin 1Daunorubicin 1Cytoreduction Surgical Procedures 1Cytarabine 1Cyclophosphamide 1Clonal Evolution 1Anti-Inflammatory Agents, Non-Steroidal 1Aminolevulinic Acid 1Ado-Trastuzumab Emtansine 1Adjuvants, Pharmaceutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasm, Residual × Cytoreduction Surgical Procedures × Clear all
NCT07567573 2026-05-05

retroESGO ov1

European Society of Gynaecological Oncology

Completed
11,383 enrolled
Gynecologic

Ovarian Neoplasms, Postoperative Complications, Recurrence, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡